- Home
- PFE vs USB Comparison
PFE vs USB Comparison
Compare PFE & USB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFE | USB |
|---|---|---|
| Founded | 1849 | 1863 |
| Country | United States | United States |
| Employees | N/A | 68520 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 89.8B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PFE | USB |
|---|---|---|
| Price | $24.24 | $60.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 19 |
| Target Price | $29.29 | ★ $60.28 |
| AVG Volume (30 Days) | ★ 32.6M | 9.0M |
| Earning Date | 05-05-2026 | 04-16-2026 |
| Dividend Yield | ★ 6.55% | 3.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $16.09 |
| Revenue Next Year | N/A | $5.36 |
| P/E Ratio | $50.29 | ★ $12.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.11 | $43.46 |
| 52 Week High | $28.75 | $61.88 |
Technical Indicators
Market Signals| Indicator | PFE | USB |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 67.37 |
| Support Level | $24.02 | $52.92 |
| Resistance Level | $26.42 | $61.19 |
| Average True Range (ATR) | 0.56 | 1.27 |
| MACD | -0.19 | 0.39 |
| Stochastic Oscillator | 19.69 | 83.66 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About USB U.S. Bancorp
With assets of around $700 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, wealth, and capital market services.